United States Biotechnology & Medical Research

Bellicum Pharmaceuticals Inc (BLCM)

Track

Track

Ticker: BLCM Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Bellicum Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Fair Richard A. President and CEO Executive Director
Transaction date
Purchase
Price
131.57
Quantity 15,202 -36.0%
Value US$3,657,421
Fair Richard A. President and CEO Executive Director
Transaction date
Purchase
Price
337.17
Quantity 22,493 +10.4%
Value US$4,126,439
Ward Shane Sr. VP and General Counsel Officer
Transaction date
Planned purchase
Price
187.80
Quantity 52,212 +46.3%
Value US$2,544,649
Fair Richard A. President and CEO Executive Director
Transaction date
Planned purchase
Price
0.99
Quantity 20,000 +304.8%
Value US$19,780
Stonehouse Jon P Non-Executive Director
Transaction date
Purchase
Price
4.56
Quantity 10,000 +inf%
Value US$45,600
Spencer David M. Chief Technology Officer Officer
Transaction date
Planned sale
Price
7.04
Quantity 10,000 -10.0%
Value US$70,413
Spencer David M. Chief Technology Officer Officer
Transaction date
Planned sale
Price
7.63
Quantity 40,000 -28.6%
Value US$305,132
Musso Alan A CFO and Treasurer Officer
Transaction date
Planned sale
Price
7.97
Quantity 6,206 -18.9%
Value US$49,466
BAKER BROS. ADVISORS LP Large shareholder
Transaction date
Sale
Price
7.91
Quantity 4,136 -6.6%
Value US$32,715
BAKER BROS. ADVISORS LP Large shareholder
Transaction date
Sale
Price
7.91
Quantity 265,708 -6.6%
Value US$2,101,671
BAKER BROS. ADVISORS LP Large shareholder
Transaction date
Sale
Price
7.91
Quantity 25,517 -6.6%
Value US$201,832
BAKER BROS. ADVISORS LP Large shareholder
Transaction date
Sale
Price
8.12
Quantity 4,548 -6.8%
Value US$36,910
BAKER BROS. ADVISORS LP Large shareholder
Transaction date
Sale
Price
8.12
Quantity 292,168 -6.8%
Value US$2,371,148
BAKER BROS. ADVISORS LP Large shareholder
Transaction date
Sale
Price
8.12
Quantity 28,058 -6.8%
Value US$227,710
BAKER BROS. ADVISORS LP Large shareholder
Transaction date
Sale
Price
8.63
Quantity 3,649 -5.2%
Value US$31,476
BAKER BROS. ADVISORS LP Large shareholder
Transaction date
Sale
Price
8.63
Quantity 234,437 -5.2%
Value US$2,022,230
BAKER BROS. ADVISORS LP Large shareholder
Transaction date
Sale
Price
8.63
Quantity 22,514 -5.2%
Value US$194,204
Smith Alan K. EVP, Technical Operations Officer
Transaction date
Planned sale
Price
9.40
Quantity 487 -18.9%
Value US$4,578
Musso Alan A CFO and Treasurer
Transaction date
Planned sale
Price
9.33
Quantity 17,117 -35.1%
Value US$159,667
Smith Alan K. EVP, Technical Operations Officer
Transaction date
Planned sale
Price
11.85
Quantity 437 -21.5%
Value US$5,178
Moseley Ken Sr. VP and General Counsel Officer
Transaction date
Planned sale
Price
12.26
Quantity 13,823 -96.6%
Value US$169,470
Spencer David M. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
11.54
Quantity 10,000 -6.7%
Value US$115,400
Musso Alan A CFO and Treasurer Officer
Transaction date
Planned sale
Price
12.24
Quantity 6,311 -10.3%
Value US$77,254
BAKER BROS. ADVISORS LP Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 151,177 +3.5%
Value US$1,814,124
BAKER BROS. ADVISORS LP Large shareholder
Transaction date
Purchase
Price
12.00
Quantity 15,489 +3.7%
Value US$185,868
Slawin Kevin M.
Transaction date
Planned sale
Price
12.54
Quantity 30,000 -9.2%
Value US$376,215
Slawin Kevin M. Chief Technology Officer Executive Director
Transaction date
Planned sale
Price
15.45
Quantity 30,000 -8.5%
Value US$463,539
Spencer David M. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
20.00
Quantity 5,000 -3.3%
Value US$100,000
Spencer David M. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
18.04
Quantity 2,033 -1.3%
Value US$36,682
Moseley Annemarie COO/EVP Clinical Development Officer
Transaction date
Planned sale
Price
18.04
Quantity 10,542 -96.0%
Value US$190,195
Moseley Annemarie COO/EVP Clinical Development Officer
Transaction date
Planned sale
Price
17.17
Quantity 14,458 -56.8%
Value US$248,310
Spencer David M. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
17.17
Quantity 2,967 -1.9%
Value US$50,942
Musso Alan A CFO and Treasurer Officer
Transaction date
Planned sale
Price
19.85
Quantity 600 -1.0%
Value US$11,907
Musso Alan A CFO and Treasurer Officer
Transaction date
Planned sale
Price
19.23
Quantity 22,427 -26.8%
Value US$431,253
Musso Alan A CFO and Treasurer Officer
Transaction date
Planned sale
Price
20.48
Quantity 6,273 -7.0%
Value US$128,480
Slawin Kevin M. Chief Technology Officer Executive Director
Transaction date
Planned sale
Price
20.11
Quantity 11,958 -3.3%
Value US$240,530
Slawin Kevin M. Chief Technology Officer Executive Director
Transaction date
Planned sale
Price
20.12
Quantity 11,258 -11.8%
Value US$226,549
Moseley Ken Sr. VP and General Counsel Officer
Transaction date
Planned sale
Price
20.10
Quantity 11,700 -97.1%
Value US$235,198
Spencer David M. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
20.19
Quantity 6,200 -3.8%
Value US$125,172
Spencer David M. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
19.68
Quantity 10,000 -5.8%
Value US$196,832
Slawin Kevin M. Chief Technology Officer Executive Director
Transaction date
Planned sale
Price
20.04
Quantity 100 -0.0%
Value US$2,004
Moseley Ken Sr. VP and General Counsel Officer
Transaction date
Planned sale
Price
20.04
Quantity 100 -22.5%
Value US$2,004
Slawin Kevin M. Chief Technology Officer Executive Director
Transaction date
Planned sale
Price
20.04
Quantity 100 -0.1%
Value US$2,004
Spencer David M. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
20.04
Quantity 300 -0.2%
Value US$6,012
Spencer David M. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
20.00
Quantity 100 -0.1%
Value US$2,000
Moseley Ken Sr. VP and General Counsel Officer
Transaction date
Planned sale
Price
20.00
Quantity 200 -36.8%
Value US$4,000
Slawin Kevin M. Chief Technology Officer Executive Director
Transaction date
Planned sale
Price
20.00
Quantity 100 -0.0%
Value US$2,000
Slawin Kevin M. Chief Technology Officer Executive Director
Transaction date
Planned sale
Price
20.00
Quantity 300 -0.3%
Value US$6,000
Spencer David M. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
20.02
Quantity 700 -0.4%
Value US$14,013
Moseley Ken Sr. VP and General Counsel Officer
Transaction date
Planned sale
Price
20.01
Quantity 1,300 -79.1%
Value US$26,018
Slawin Kevin M. Chief Technology Officer Executive Director
Transaction date
Planned sale
Price
20.01
Quantity 1,206 -0.3%
Value US$24,129
Slawin Kevin M. Chief Technology Officer Executive Director
Transaction date
Planned sale
Price
20.02
Quantity 1,400 -1.4%
Value US$28,024
Moseley Ken Sr. VP and General Counsel Officer
Transaction date
Planned sale
Price
20.00
Quantity 700 -67.0%
Value US$14,000
Slawin Kevin M. Chief Technology Officer Executive Director
Transaction date
Planned sale
Price
20.00
Quantity 636 -0.2%
Value US$12,720
Spencer David M. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
20.01
Quantity 1,700 -1.0%
Value US$34,015
Slawin Kevin M. Chief Technology Officer Executive Director
Transaction date
Planned sale
Price
20.00
Quantity 942 -1.0%
Value US$18,840
Slawin Kevin M. Chief Technology Officer Executive Director
Transaction date
Planned sale
Price
20.01
Quantity 2,000 -0.5%
Value US$40,020
Slawin Kevin M. Chief Technology Officer Executive Director
Transaction date
Planned sale
Price
19.27
Quantity 29,000 -7.3%
Value US$558,911
Slawin Kevin M. Chief Technology Officer Executive Director
Transaction date
Planned sale
Price
20.01
Quantity 1,873 -1.9%
Value US$37,470
Moseley Ken Sr. VP and General Counsel Officer
Transaction date
Planned sale
Price
20.00
Quantity 1,000 -74.4%
Value US$20,000
Slawin Kevin M. Chief Technology Officer Executive Director
Transaction date
Planned sale
Price
19.27
Quantity 34,127 -25.4%
Value US$657,542
Spencer David M. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
20.00
Quantity 1,000 -0.6%
Value US$20,000
Slawin Kevin M. Chief Technology Officer Executive Director
Transaction date
Planned sale
Price
15.00
Quantity 15,000 -3.6%
Value US$225,000
Spencer David M. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
15.00
Quantity 10,000 -5.4%
Value US$150,000
Slawin Kevin M. Chief Technology Officer Executive Director
Transaction date
Planned sale
Price
13.99
Quantity 2,719 -2.0%
Value US$38,044
Slawin Kevin M. Chief Technology Officer Executive Director
Transaction date
Planned sale
Price
13.72
Quantity 22,281 -14.0%
Value US$305,677
Moseley Annemarie COO/EVP Clinical Development Officer
Transaction date
Planned sale
Price
13.00
Quantity 6,765 -96.4%
Value US$87,945
Moseley Annemarie COO/EVP Clinical Development Officer
Transaction date
Planned sale
Price
13.00
Quantity 18,235 -98.6%
Value US$237,055
Moseley Ken Sr. VP and General Counsel Officer
Transaction date
Planned sale
Price
13.00
Quantity 15,000 -98.7%
Value US$195,000
Slawin Kevin M. Chief Technology Officer Executive Director
Transaction date
Planned sale
Price
11.89
Quantity 200 -0.0%
Value US$2,377
Slawin Kevin M. Chief Technology Officer Executive Director
Transaction date
Planned sale
Price
11.42
Quantity 29,800 -6.7%
Value US$340,411
Slawin Kevin M. Chief Technology Officer Executive Director
Transaction date
Planned sale
Price
11.43
Quantity 25,000 -13.6%
Value US$285,710
Moseley Annemarie COO/EVP Clinical Development Officer
Transaction date
Planned sale
Price
19.96
Quantity 2,300 -90.2%
Value US$45,903
Moseley Annemarie COO/EVP Clinical Development Officer
Transaction date
Planned sale
Price
19.01
Quantity 32,700 -92.8%
Value US$621,591
Slawin Kevin M. Chief Technology Officer Executive Director
Transaction date
Planned sale
Price
20.65
Quantity 4,000 -1.0%
Value US$82,585
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-03-19 2020-03-17 B Purchase
Fair Richard A.

President and CEO

Executive Director
15,202 -36.0%
131.57
US$3,657,421 		15,202 -36.0% 131.57 US$3,657,421
2019-09-11 2019-09-10 B Purchase
Fair Richard A.

President and CEO

Executive Director
22,493 +10.4%
337.17
US$4,126,439 		22,493 +10.4% 337.17 US$4,126,439
2019-08-30 2019-08-29 PP Planned purchase Ward Shane

Sr. VP and General Counsel

Officer
52,212 +46.3%
187.80
US$2,544,649 		52,212 +46.3% 187.80 US$2,544,649
2019-08-23 2019-08-21 PP Planned purchase Fair Richard A.

President and CEO

Executive Director
20,000 +304.8%
0.99
US$19,780 		20,000 +304.8% 0.99 US$19,780
2018-11-13 2018-11-09 B Purchase Stonehouse Jon P Non-Executive Director
10,000 +inf%
4.56
US$45,600 		10,000 +inf% 4.56 US$45,600
2018-09-05 2018-09-04 PlS Planned sale Spencer David M.

Chief Technology Officer

Officer
10,000 -10.0%
7.04
US$70,413 		10,000 -10.0% 7.04 US$70,413
2018-07-20 2018-07-18 PlS Planned sale Spencer David M.

Chief Technology Officer

Officer
40,000 -28.6%
7.63
US$305,132 		40,000 -28.6% 7.63 US$305,132
2018-05-29 2018-05-25 PlS Planned sale Musso Alan A

CFO and Treasurer

Officer
6,206 -18.9%
7.97
US$49,466 		6,206 -18.9% 7.97 US$49,466
2018-01-19 2018-01-19 S Sale BAKER BROS. ADVISORS LP Large shareholder
4,136 -6.6%
7.91
US$32,715 		4,136 -6.6% 7.91 US$32,715
2018-01-19 2018-01-19 S Sale BAKER BROS. ADVISORS LP Large shareholder
265,708 -6.6%
7.91
US$2,101,671 		265,708 -6.6% 7.91 US$2,101,671
2018-01-19 2018-01-19 S Sale BAKER BROS. ADVISORS LP Large shareholder
25,517 -6.6%
7.91
US$201,832 		25,517 -6.6% 7.91 US$201,832
2018-01-19 2018-01-18 S Sale BAKER BROS. ADVISORS LP Large shareholder
4,548 -6.8%
8.12
US$36,910 		4,548 -6.8% 8.12 US$36,910
2018-01-19 2018-01-18 S Sale BAKER BROS. ADVISORS LP Large shareholder
292,168 -6.8%
8.12
US$2,371,148 		292,168 -6.8% 8.12 US$2,371,148
2018-01-19 2018-01-18 S Sale BAKER BROS. ADVISORS LP Large shareholder
28,058 -6.8%
8.12
US$227,710 		28,058 -6.8% 8.12 US$227,710
2018-01-19 2018-01-17 S Sale BAKER BROS. ADVISORS LP Large shareholder
3,649 -5.2%
8.63
US$31,476 		3,649 -5.2% 8.63 US$31,476
2018-01-19 2018-01-17 S Sale BAKER BROS. ADVISORS LP Large shareholder
234,437 -5.2%
8.63
US$2,022,230 		234,437 -5.2% 8.63 US$2,022,230
2018-01-19 2018-01-17 S Sale BAKER BROS. ADVISORS LP Large shareholder
22,514 -5.2%
8.63
US$194,204 		22,514 -5.2% 8.63 US$194,204
2018-01-11 2018-01-09 PlS Planned sale Smith Alan K.

EVP, Technical Operations

Officer
487 -18.9%
9.40
US$4,578 		487 -18.9% 9.40 US$4,578
2017-12-13 2017-12-11 PlS Planned sale Musso Alan A

CFO and Treasurer
17,117 -35.1%
9.33
US$159,667 		17,117 -35.1% 9.33 US$159,667
2017-07-26 2017-07-24 PlS Planned sale Smith Alan K.

EVP, Technical Operations

Officer
437 -21.5%
11.85
US$5,178 		437 -21.5% 11.85 US$5,178
2017-07-17 2017-07-13 PlS Planned sale Moseley Ken

Sr. VP and General Counsel

Officer
13,823 -96.6%
12.26
US$169,470 		13,823 -96.6% 12.26 US$169,470
2017-07-12 2017-07-10 PlS Planned sale Spencer David M.

Chief Scientific Officer

Officer
10,000 -6.7%
11.54
US$115,400 		10,000 -6.7% 11.54 US$115,400
2017-05-26 2017-05-25 PlS Planned sale
Musso Alan A

CFO and Treasurer

Officer
6,311 -10.3%
12.24
US$77,254 		6,311 -10.3% 12.24 US$77,254
2017-03-28 2017-03-24 B Purchase BAKER BROS. ADVISORS LP Large shareholder
151,177 +3.5%
12.00
US$1,814,124 		151,177 +3.5% 12.00 US$1,814,124
2017-03-28 2017-03-24 B Purchase BAKER BROS. ADVISORS LP Large shareholder
15,489 +3.7%
12.00
US$185,868 		15,489 +3.7% 12.00 US$185,868
2017-02-09 2017-02-07 PlS Planned sale Slawin Kevin M.
30,000 -9.2%
12.54
US$376,215 		30,000 -9.2% 12.54 US$376,215
2016-12-19 2016-12-15 PlS Planned sale Slawin Kevin M.

Chief Technology Officer

Executive Director
30,000 -8.5%
15.45
US$463,539 		30,000 -8.5% 15.45 US$463,539
2016-12-05 2016-12-05 PlS Planned sale Spencer David M.

Chief Scientific Officer

Officer
5,000 -3.3%
20.00
US$100,000 		5,000 -3.3% 20.00 US$100,000
2016-12-05 2016-12-01 PlS Planned sale Spencer David M.

Chief Scientific Officer

Officer
2,033 -1.3%
18.04
US$36,682 		2,033 -1.3% 18.04 US$36,682
2016-12-05 2016-12-01 PlS Planned sale Moseley Annemarie

COO/EVP Clinical Development

Officer
10,542 -96.0%
18.04
US$190,195 		10,542 -96.0% 18.04 US$190,195
2016-12-05 2016-12-01 PlS Planned sale Moseley Annemarie

COO/EVP Clinical Development

Officer
14,458 -56.8%
17.17
US$248,310 		14,458 -56.8% 17.17 US$248,310
2016-12-05 2016-12-01 PlS Planned sale
Spencer David M.

Chief Scientific Officer

Officer
2,967 -1.9%
17.17
US$50,942 		2,967 -1.9% 17.17 US$50,942
2016-11-29 2016-11-28 PlS Planned sale Musso Alan A

CFO and Treasurer

Officer
600 -1.0%
19.85
US$11,907 		600 -1.0% 19.85 US$11,907
2016-11-29 2016-11-28 PlS Planned sale Musso Alan A

CFO and Treasurer

Officer
22,427 -26.8%
19.23
US$431,253 		22,427 -26.8% 19.23 US$431,253
2016-11-29 2016-11-25 PlS Planned sale
Musso Alan A

CFO and Treasurer

Officer
6,273 -7.0%
20.48
US$128,480 		6,273 -7.0% 20.48 US$128,480
2016-09-23 2016-09-23 PlS Planned sale Slawin Kevin M.

Chief Technology Officer

Executive Director
11,958 -3.3%
20.11
US$240,530 		11,958 -3.3% 20.11 US$240,530
2016-09-23 2016-09-23 PlS Planned sale Slawin Kevin M.

Chief Technology Officer

Executive Director
11,258 -11.8%
20.12
US$226,549 		11,258 -11.8% 20.12 US$226,549
2016-09-23 2016-09-23 PlS Planned sale Moseley Ken

Sr. VP and General Counsel

Officer
11,700 -97.1%
20.10
US$235,198 		11,700 -97.1% 20.10 US$235,198
2016-09-23 2016-09-23 PlS Planned sale Spencer David M.

Chief Scientific Officer

Officer
6,200 -3.8%
20.19
US$125,172 		6,200 -3.8% 20.19 US$125,172
2016-09-23 2016-09-22 PlS Planned sale Spencer David M.

Chief Scientific Officer

Officer
10,000 -5.8%
19.68
US$196,832 		10,000 -5.8% 19.68 US$196,832
2016-09-23 2016-09-21 PlS Planned sale Slawin Kevin M.

Chief Technology Officer

Executive Director
100 -0.0%
20.04
US$2,004 		100 -0.0% 20.04 US$2,004
2016-09-23 2016-09-21 PlS Planned sale Moseley Ken

Sr. VP and General Counsel

Officer
100 -22.5%
20.04
US$2,004 		100 -22.5% 20.04 US$2,004
2016-09-23 2016-09-21 PlS Planned sale
Slawin Kevin M.

Chief Technology Officer

Executive Director
100 -0.1%
20.04
US$2,004 		100 -0.1% 20.04 US$2,004
2016-09-23 2016-09-21 PlS Planned sale
Spencer David M.

Chief Scientific Officer

Officer
300 -0.2%
20.04
US$6,012 		300 -0.2% 20.04 US$6,012
2016-09-20 2016-09-20 PlS Planned sale Spencer David M.

Chief Scientific Officer

Officer
100 -0.1%
20.00
US$2,000 		100 -0.1% 20.00 US$2,000
2016-09-20 2016-09-20 PlS Planned sale Moseley Ken

Sr. VP and General Counsel

Officer
200 -36.8%
20.00
US$4,000 		200 -36.8% 20.00 US$4,000
2016-09-20 2016-09-20 PlS Planned sale Slawin Kevin M.

Chief Technology Officer

Executive Director
100 -0.0%
20.00
US$2,000 		100 -0.0% 20.00 US$2,000
2016-09-20 2016-09-20 PlS Planned sale Slawin Kevin M.

Chief Technology Officer

Executive Director
300 -0.3%
20.00
US$6,000 		300 -0.3% 20.00 US$6,000
2016-09-20 2016-09-19 PlS Planned sale Spencer David M.

Chief Scientific Officer

Officer
700 -0.4%
20.02
US$14,013 		700 -0.4% 20.02 US$14,013
2016-09-20 2016-09-19 PlS Planned sale Moseley Ken

Sr. VP and General Counsel

Officer
1,300 -79.1%
20.01
US$26,018 		1,300 -79.1% 20.01 US$26,018
2016-09-20 2016-09-19 PlS Planned sale Slawin Kevin M.

Chief Technology Officer

Executive Director
1,206 -0.3%
20.01
US$24,129 		1,206 -0.3% 20.01 US$24,129
2016-09-20 2016-09-19 PlS Planned sale Slawin Kevin M.

Chief Technology Officer

Executive Director
1,400 -1.4%
20.02
US$28,024 		1,400 -1.4% 20.02 US$28,024
2016-09-20 2016-09-16 PlS Planned sale Moseley Ken

Sr. VP and General Counsel

Officer
700 -67.0%
20.00
US$14,000 		700 -67.0% 20.00 US$14,000
2016-09-20 2016-09-16 PlS Planned sale Slawin Kevin M.

Chief Technology Officer

Executive Director
636 -0.2%
20.00
US$12,720 		636 -0.2% 20.00 US$12,720
2016-09-20 2016-09-16 PlS Planned sale
Spencer David M.

Chief Scientific Officer

Officer
1,700 -1.0%
20.01
US$34,015 		1,700 -1.0% 20.01 US$34,015
2016-09-20 2016-09-16 PlS Planned sale Slawin Kevin M.

Chief Technology Officer

Executive Director
942 -1.0%
20.00
US$18,840 		942 -1.0% 20.00 US$18,840
2016-08-17 2016-08-15 PlS Planned sale Slawin Kevin M.

Chief Technology Officer

Executive Director
2,000 -0.5%
20.01
US$40,020 		2,000 -0.5% 20.01 US$40,020
2016-08-17 2016-08-15 PlS Planned sale Slawin Kevin M.

Chief Technology Officer

Executive Director
29,000 -7.3%
19.27
US$558,911 		29,000 -7.3% 19.27 US$558,911
2016-08-17 2016-08-15 PlS Planned sale Slawin Kevin M.

Chief Technology Officer

Executive Director
1,873 -1.9%
20.01
US$37,470 		1,873 -1.9% 20.01 US$37,470
2016-08-17 2016-08-15 PlS Planned sale Moseley Ken

Sr. VP and General Counsel

Officer
1,000 -74.4%
20.00
US$20,000 		1,000 -74.4% 20.00 US$20,000
2016-08-17 2016-08-15 PlS Planned sale
Slawin Kevin M.

Chief Technology Officer

Executive Director
34,127 -25.4%
19.27
US$657,542 		34,127 -25.4% 19.27 US$657,542
2016-08-17 2016-08-15 PlS Planned sale
Spencer David M.

Chief Scientific Officer

Officer
1,000 -0.6%
20.00
US$20,000 		1,000 -0.6% 20.00 US$20,000
2016-07-29 2016-07-27 PlS Planned sale
Slawin Kevin M.

Chief Technology Officer

Executive Director
15,000 -3.6%
15.00
US$225,000 		15,000 -3.6% 15.00 US$225,000
2016-07-29 2016-07-27 PlS Planned sale Spencer David M.

Chief Scientific Officer

Officer
10,000 -5.4%
15.00
US$150,000 		10,000 -5.4% 15.00 US$150,000
2016-07-19 2016-07-18 PlS Planned sale Slawin Kevin M.

Chief Technology Officer

Executive Director
2,719 -2.0%
13.99
US$38,044 		2,719 -2.0% 13.99 US$38,044
2016-07-19 2016-07-15 PlS Planned sale
Slawin Kevin M.

Chief Technology Officer

Executive Director
22,281 -14.0%
13.72
US$305,677 		22,281 -14.0% 13.72 US$305,677
2016-06-06 2016-06-02 PlS Planned sale Moseley Annemarie

COO/EVP Clinical Development

Officer
6,765 -96.4%
13.00
US$87,945 		6,765 -96.4% 13.00 US$87,945
2016-06-06 2016-06-02 PlS Planned sale Moseley Annemarie

COO/EVP Clinical Development

Officer
18,235 -98.6%
13.00
US$237,055 		18,235 -98.6% 13.00 US$237,055
2016-06-06 2016-06-02 PlS Planned sale Moseley Ken

Sr. VP and General Counsel

Officer
15,000 -98.7%
13.00
US$195,000 		15,000 -98.7% 13.00 US$195,000
2016-04-26 2016-04-22 PlS Planned sale Slawin Kevin M.

Chief Technology Officer

Executive Director
200 -0.0%
11.89
US$2,377 		200 -0.0% 11.89 US$2,377
2016-04-26 2016-04-22 PlS Planned sale Slawin Kevin M.

Chief Technology Officer

Executive Director
29,800 -6.7%
11.42
US$340,411 		29,800 -6.7% 11.42 US$340,411
2016-04-26 2016-04-22 PlS Planned sale
Slawin Kevin M.

Chief Technology Officer

Executive Director
25,000 -13.6%
11.43
US$285,710 		25,000 -13.6% 11.43 US$285,710
2016-01-06 2016-01-04 PlS Planned sale Moseley Annemarie

COO/EVP Clinical Development

Officer
2,300 -90.2%
19.96
US$45,903 		2,300 -90.2% 19.96 US$45,903
2016-01-06 2016-01-04 PlS Planned sale Moseley Annemarie

COO/EVP Clinical Development

Officer
32,700 -92.8%
19.01
US$621,591 		32,700 -92.8% 19.01 US$621,591
2015-11-18 2015-11-16 PlS Planned sale Slawin Kevin M.

Chief Technology Officer

Executive Director
4,000 -1.0%
20.65
US$82,585 		4,000 -1.0% 20.65 US$82,585
Explore more

More insider trading research around Bellicum Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America